Compound ID | 1805

Update compound information

INBRX-111

Class: Antibody (monoclonal antibody [mAb])

Spectrum of activity: Gram-negative
Details of activity: INBRX-111 is a multi-specific and multi-epitopic anti-virulence/opsonizing monoclonal antibody targeting Pseudomonas aeruginosa
Description: Humanized monoclonal antibody
Institute where first reported: Inhibrx
Year first mentioned: 2017
Highest developmental phase: Preclinical
Development status: Inactive (as of 2022)
External links:
Citation: https://www.prnewswire.com/news-releases/inhibrx-wins-carb-x-award-of-up-to-60m-to-accelerate-development-of-its-novel-antibody-inbrx-111-to-treat-pseudomonas-infections-300546046.html

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.